Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125278551 | 12527855 | 1 | I | 201601 | 20160701 | 20160705 | 20160705 | EXP | JP-009507513-1607JPN001673 | MERCK | 82.00 | YR | M | Y | 65.00000 | KG | 20160705 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125278551 | 12527855 | 1 | PS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 75 MG/M2, QD | 21029 | 75 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 2 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 3 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 4 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 5 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 6 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 7 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 8 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 9 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 10 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 11 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 12 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 13 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 14 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 15 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 16 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 17 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 18 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 19 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 20 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 21 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||||
| 125278551 | 12527855 | 22 | C | LENDORMIN | BROTIZOLAM | 1 | Oral | UNK, FORMULATION: POR | U | 0 | |||||||||
| 125278551 | 12527855 | 23 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | UNK, FORMULATION: POR | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125278551 | 12527855 | 1 | Anaplastic astrocytoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125278551 | 12527855 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125278551 | 12527855 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125278551 | 12527855 | 1 | 20110518 | 20110928 | 0 | |
| 125278551 | 12527855 | 2 | 20111027 | 20111031 | 0 | |
| 125278551 | 12527855 | 3 | 20111201 | 20111205 | 0 | |
| 125278551 | 12527855 | 4 | 20120105 | 20120109 | 0 | |
| 125278551 | 12527855 | 5 | 20120202 | 20120206 | 0 | |
| 125278551 | 12527855 | 6 | 20120302 | 20120306 | 0 | |
| 125278551 | 12527855 | 7 | 20120330 | 20120403 | 0 | |
| 125278551 | 12527855 | 8 | 20120427 | 20120501 | 0 | |
| 125278551 | 12527855 | 9 | 20120525 | 20120529 | 0 | |
| 125278551 | 12527855 | 10 | 20120622 | 20120626 | 0 | |
| 125278551 | 12527855 | 11 | 20120720 | 20120724 | 0 | |
| 125278551 | 12527855 | 12 | 20120817 | 20120821 | 0 | |
| 125278551 | 12527855 | 13 | 20120914 | 20120918 | 0 | |
| 125278551 | 12527855 | 14 | 20121012 | 20121016 | 0 | |
| 125278551 | 12527855 | 15 | 20121109 | 20121113 | 0 | |
| 125278551 | 12527855 | 16 | 20121207 | 20121211 | 0 | |
| 125278551 | 12527855 | 17 | 20130111 | 20130115 | 0 | |
| 125278551 | 12527855 | 18 | 20130208 | 20130212 | 0 | |
| 125278551 | 12527855 | 19 | 20130317 | 20130321 | 0 | |
| 125278551 | 12527855 | 20 | 20130419 | 20130423 | 0 | |
| 125278551 | 12527855 | 21 | 20130517 | 20130521 | 0 | |
| 125278551 | 12527855 | 22 | 20110728 | 0 | ||
| 125278551 | 12527855 | 23 | 20110825 | 0 |